News Focus
News Focus
Followers 84
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 241924

Saturday, 11/07/2015 7:01:46 PM

Saturday, November 07, 2015 7:01:46 PM

Post# of 347009

Gary E. Gilbert, MD
VA Boston Healthcare System, Harvard Medical School
Boston, MA
Platelet Phosphatidylserine Exposure, Survival and Blood Coagulation in Mice Lacking TMEM16F



Gary Gilbert.... I'm actually a bit surprised at this exposure into the VA Boston

----------------------------

Gary Gilbert

Principal Investigator at Research in blood coagulation, emphasizing membrane interface

Greater Boston Area
Research

Current
VA Boston Healthcare System, Harvard University, Research in blood coagulation, emphasizing membrane interface

Education
Tufts University

286
connections


Experience

Chief, Hematology and Oncology
VA Boston Healthcare System
2015 – Present (less than a year)VA Boston Healthcare System

Associate Prof of Medicine
Harvard University
2011 – Present (4 years)

Principal Investigator
Research in blood coagulation, emphasizing membrane interface
September 1989 – Present (26 years 3 months)VA Boston Healthcare System

My laboratory focuses on coagulation factor VIII and lactadherin a.k.a. mfg-e8. We are particularly interested in the manner in which chemical and physical changes of the membrane regulate coagulation activity of the blood
..
..
..
https://www.linkedin.com/pub/gary-gilbert/72/440/652


"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y